Altigen Communs Inc

Good afternoon everyone and welcome to the Altogen Technologies second quarter and fiscal year 2026 results conference call. At this time, all participants are in a listen only mode and a question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your phone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Gary Stone, CFO of Altogen Technologies. You may begin.

Thank you, Jenny. Good afternoon, everyone, and welcome to Altogen Technologies' earnings call for the second quarter of fiscal 2026. Joining me on the call today is Jerry Fleming, our Chief Executive Officer, Joe Hamblin, our President and Chief Operating Officer, and as mentioned, I'm Gary Stone, the Chief Financial Officer. Earlier today, we issued an earnings release reporting financial results for the period ended March 31, 2026. This release can be found on our IR website at www.altagen.com. We've also arranged a replay of this call, which may be accessed by phone. This replay will be available approximately one hour after the call's completion and remain in effect for 90 days. The call can also be accessed from the investor relations section of our website. Before we begin our formal remarks, we need to remind everyone that today's call may contain forward-looking information regarding future events and the future financial performance of the company. We wish to caution you that such expectations and our beliefs are just predictions and actual results may differ materially due to certain risks and uncertainties that pertain to our business. We refer to you the financial disclosures filed periodically by the company with the OTCQB over-the-counter market. Specifically, the company's audited annual report for the fiscal year ended September 30, 2025, as well as the safe harbor statement in the press release today the company issued earlier. These documents contain important risk factors that could cause actual results to differ materially from those contained in the company's projections or forward-looking statements. AlphaGyn assumes no obligation to revise any forward-looking information contained in today's call. In addition, during today's call, we will be referring to certain non-GAAP financial measures, such as adjusted EBITDA. These non-GAAP measures are not superior to or a replacement for the comparable GAAP measures, but we believe these measures help investors gain a more complete understanding of our results. So with that, I will turn the call over to Jerry for opening remarks.

Jerry?